Princeton Capital Management’s GSK GSK Stock Holding History

Princeton Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-526	Closed	-$28K	–	138
2019 Q3	$28K	Sell	526 -493	-48%	-$25.4K	0.01%	181
2019 Q2	$51K	Hold	1,019	–	–	0.02%	150
2019 Q1	$53K	Buy	1,019 +493	+94%	+$24.6K	0.03%	147
2018 Q4	$25K	Hold	526	–	–	0.01%	181
2018 Q3	$26K	Hold	526	–	–	0.01%	202
2018 Q2	$27K	Hold	526	–	–	0.01%	210
2018 Q1	$26K	Buy	+526	New	+$24.5K	0.01%	207

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Princeton Capital Management's GSK Position: Q4 2019 in Review

Princeton Capital Management sold out of GSK (GSK) in Q4 2019, closing a stake of 526 shares — an estimated $28K sold.

Princeton Capital Management first reported a position in GSK in Q1 2018 and held it in 7 quarters. The position peaked at $53K in Q1 2019. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

Princeton Capital Management reported no remaining GSK position as of Q4 2019 after selling out during the quarter.
Princeton Capital Management sold 526 GSK shares in Q4 2019, an estimated $28K.
Princeton Capital Management first reported a position in GSK in Q1 2018 and held it in 7 quarters.
Princeton Capital Management's GSK position peaked at $53K in Q1 2019.
894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Princeton Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.